Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma.
about
Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingHepatocellular Cancer: New Kids on the BlockEupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma.Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signalingIn vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot studypERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma.Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer.Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer.Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.Hepatitis C virus and its protein NS4B activate the cancer-related STAT3 pathway via the endoplasmic reticulum overload response.Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib TreatmentHepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
P2860
Q26783895-301194A5-28F7-4C7F-9AB5-46DB146D6246Q27022642-C2E1BA67-E4BC-4099-923C-787B55D664FAQ33837248-992650C8-0060-4C7B-97D0-04848AD671AAQ35742375-34B3E69D-FF0F-4C33-B9AC-27CEDDDF3FA8Q36338014-960921E1-8981-41B8-A46C-EE2D18E7D6C3Q36771900-4C18FAD6-B24E-42EF-AD8D-2CBCE5ED60E4Q37086246-76602052-B463-47C0-B046-067BA119E8E3Q37610216-BFF07D7C-DF9C-49C2-A7A5-312517865C07Q37707033-FF9EE92B-2773-4071-9692-24C071114EC5Q38699445-95BA6C5F-DCB3-48E5-B22B-0635991A9DD7Q40754024-AAA07A3A-C080-4715-BDE7-3A70C13C7608Q41544562-BD19088F-8320-4F0E-95D5-222ECD2373EAQ41637262-3023EE27-E243-4B33-8985-257034D09DB8Q48236551-E95F91C6-2507-433A-AD49-05E3377437A7Q50935448-662A97B5-54B7-4A09-BCF7-1CD3CEDEE056
P2860
Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Autocrine vascular endothelial ...... y in hepatocellular carcinoma.
@en
Autocrine vascular endothelial ...... y in hepatocellular carcinoma.
@nl
type
label
Autocrine vascular endothelial ...... y in hepatocellular carcinoma.
@en
Autocrine vascular endothelial ...... y in hepatocellular carcinoma.
@nl
prefLabel
Autocrine vascular endothelial ...... y in hepatocellular carcinoma.
@en
Autocrine vascular endothelial ...... y in hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Autocrine vascular endothelial ...... y in hepatocellular carcinoma.
@en
P2093
Baogang Peng
Ming Kuang
Minhu Chen
Riccardo Lencioni
Shunli Shen
P2860
P304
P356
10.1002/HEP.27236
P407
P577
2014-08-25T00:00:00Z